🇺🇸 early initiation of treatment with Risperdal Consta in United States

early initiation of treatment with Risperdal Consta (early initiation of treatment with Risperdal Consta) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

early initiation of treatment with Risperdal Consta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is early initiation of treatment with Risperdal Consta approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for early initiation of treatment with Risperdal Consta in United States?

Janssen Pharmaceutica N.V., Belgium is the originator. The local marketing authorisation holder may differ — check the official source linked above.